BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Cisplatin
,
rs3825942
,
CXCL2
,
Hepatitis
,
Pancreas
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
5-HT3-antagonists
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for 5-HT3-antagonists
Explore Curated Studies Results
Literature
Most Relevant Literature
Combination of 5-HT3 Antagonist and Dexamethasone Is Superior to 5-HT3 Antagonist Alone for PONV Pro…
In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
What is the ideal combination antiemetic regimen?
Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a sys…
Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a syste…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotensi…
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible…
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagon…
Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resect…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ